Stocktoria
Arcutis Biotherapeutics, Inc. ARQT
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-01-31
Chart by TradingView
4/9
Piotroski F — financial health
-3.68
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $376.1M | $196.5M | $29.2M | $3.7M | $0 |
| Operating income | -$12.2M | -$128.4M | -$241.1M | -$301.6M | -$206.5M |
| Net income | -$16.1M | -$140.0M | -$262.1M | -$311.5M | -$206.4M |
| Operating cash flow | -$5.6M | -$112.2M | -$247.1M | -$257.7M | -$174.6M |
| Free cash flow | -$6.3M | -$112.3M | -$247.5M | -$258.0M | -$175.6M |
| Total assets | $433.0M | $348.9M | $341.4M | $449.3M | $408.2M |
| Total liabilities | $243.5M | $191.3M | $252.7M | $239.7M | $110.5M |
| Shareholders' equity | $189.5M | $157.5M | $88.7M | $209.6M | $297.7M |
| Ratios | |||||
| Operating margin | -3.3% | -65.3% | -826.1% | -8183.0% | — |
| Net margin | -4.3% | -71.3% | -898.2% | -8449.8% | — |
| FCF margin | -1.7% | -57.1% | -848.0% | -7000.8% | — |
| Return on assets | -3.7% | -40.1% | -76.8% | -69.3% | -50.6% |
| Return on equity | -8.5% | -88.9% | -295.6% | -148.6% | -69.3% |
| Debt / equity | 0.58× | 0.68× | 2.28× | 0.94× | 0.24× |
| Current ratio | 3.17 | 4.15 | 7.08 | 11.57 | 12.09 |
| Revenue growth | 91.3% | 573.4% | 691.8% | — | — |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 590,877 | $13.9M |
| RENAISSANCE TECHNOLOGIES LLC | 440,999 | $10.4M |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -3.68 (distress)
- Working capital / assets 0.65
- Retained earnings / assets -2.629
- EBIT / assets -0.028
- Equity / liabilities 0.778
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001787306 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.